COTXF (Coiled Therapeutics) ROCE %: -151.84% (As of Dec. 2025)


COTXF Coiled Therapeutics PLC COTXF
21 GF Score
Price $0.15
! 4 Warning Signs
View Full Analysis

What is Coiled Therapeutics ROCE %?

Coiled Therapeutics COTXF 21 ROCE % is -151.84% as of Dec. 2025. GuruFocus rates COTXF with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Coiled Therapeutics's annualized ROCE % for the quarter that ended in Dec. 2025 was -151.84%.

Coiled Therapeutics  (OTCPK:COTXF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Coiled Therapeutics ROCE % Related Terms

Coiled Therapeutics ROCE % Historical Data

* Premium members only.

The historical data trend for Coiled Therapeutics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coiled Therapeutics ROCE % Chart

Coiled Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
0.00 -26.67 -29.76 -21.35 -92.17

Coiled Therapeutics Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only -31.79 -25.15 -18.47 -20.70 -151.84
COTXF
21GF Score
Coiled Therapeutics PLC COTXF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coiled Therapeutics ROCE % Calculation

Coiled Therapeutics's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-4.506/( ( (7.271 - 0.733) + (3.605 - 0.365) )/ 2 )
=-4.506/( (6.538+3.24)/ 2 )
=-4.506/4.889
=-92.17 %

Coiled Therapeutics's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-7.646/( ( (7.682 - 0.851) + (3.605 - 0.365) )/ 2 )
=-7.646/( ( 6.831 + 3.24 )/ 2 )
=-7.646/5.0355
=-151.84 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -151.84% mean?
Coiled Therapeutics (COTXF) has a ROCE % of -151.84% as of Dec. 2025.
Is Coiled Therapeutics' ROCE % too high?
Coiled Therapeutics' current ROCE % is -151.84%. Overall, Coiled Therapeutics has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Coiled Therapeutics' ROCE % compare to VRTX and REGN?
Coiled Therapeutics' ROCE % of -151.84% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Coiled Therapeutics's current ROCE % is -151.84%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coiled Therapeutics stock overvalued right now?
Coiled Therapeutics (COTXF) has a current ROCE % of -151.84%. The current ROCE % is -151.84%. Coiled Therapeutics' overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Coiled Therapeutics (COTXF), the current ROCE % is -151.84% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Coiled Therapeutics Business Description

Other Exchanges COIL:UK0AG0:Germany
Address 85 Great Portland Street, First Floor, London, GBR, W1W 7LT
Coiled Therapeutics PLC principal activity of the Company is to develop pre-clinical next generation medicines focused on hard-to-treat cancers. The Group operated in the single business segment of biotechnology.
21GF Score

Get the complete analysis for COTXF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price